Cargando…
Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266603/ https://www.ncbi.nlm.nih.gov/pubmed/35865398 http://dx.doi.org/10.4084/MJHID.2022.056 |
| _version_ | 1784743508250198016 |
|---|---|
| author | Sgherza, Nicola Zucano, Stefania Vitucci, Angelantonio Palma, Antonio Tarantini, Francesco Campanale, Daniela Vimercati, Luigi Larocca, Angela Maria Vittoria Visceglie, Domenico Acquafredda, Amalia Ostuni, Angelo Di Gennaro, Daniela Vitucci, Carmen Tafuri, Silvio Musto, Pellegrino |
| author_facet | Sgherza, Nicola Zucano, Stefania Vitucci, Angelantonio Palma, Antonio Tarantini, Francesco Campanale, Daniela Vimercati, Luigi Larocca, Angela Maria Vittoria Visceglie, Domenico Acquafredda, Amalia Ostuni, Angelo Di Gennaro, Daniela Vitucci, Carmen Tafuri, Silvio Musto, Pellegrino |
| author_sort | Sgherza, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9266603 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Università Cattolica del Sacro Cuore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92666032022-07-20 Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients Sgherza, Nicola Zucano, Stefania Vitucci, Angelantonio Palma, Antonio Tarantini, Francesco Campanale, Daniela Vimercati, Luigi Larocca, Angela Maria Vittoria Visceglie, Domenico Acquafredda, Amalia Ostuni, Angelo Di Gennaro, Daniela Vitucci, Carmen Tafuri, Silvio Musto, Pellegrino Mediterr J Hematol Infect Dis Scientific Letter Università Cattolica del Sacro Cuore 2022-07-01 /pmc/articles/PMC9266603/ /pubmed/35865398 http://dx.doi.org/10.4084/MJHID.2022.056 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Scientific Letter Sgherza, Nicola Zucano, Stefania Vitucci, Angelantonio Palma, Antonio Tarantini, Francesco Campanale, Daniela Vimercati, Luigi Larocca, Angela Maria Vittoria Visceglie, Domenico Acquafredda, Amalia Ostuni, Angelo Di Gennaro, Daniela Vitucci, Carmen Tafuri, Silvio Musto, Pellegrino Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients |
| title | Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients |
| title_full | Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients |
| title_fullStr | Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients |
| title_full_unstemmed | Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients |
| title_short | Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients |
| title_sort | prospective, case-control study of serological response after two doses of bnt162b2 anti-sars-cov-2 mrna vaccine in transfusion-dependent thalassemic patients |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266603/ https://www.ncbi.nlm.nih.gov/pubmed/35865398 http://dx.doi.org/10.4084/MJHID.2022.056 |
| work_keys_str_mv | AT sgherzanicola prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT zucanostefania prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT vitucciangelantonio prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT palmaantonio prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT tarantinifrancesco prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT campanaledaniela prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT vimercatiluigi prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT laroccaangelamariavittoria prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT viscegliedomenico prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT acquafreddaamalia prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT ostuniangelo prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT digennarodaniela prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT vituccicarmen prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT tafurisilvio prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT mustopellegrino prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients |